MedPath

Comparison Therapeutic Effects of Ketotifen Fumarate Drop and Ketotifen Pill in Patients with Allergic Rhinitis

Not Applicable
Conditions
allergic rhinitis.
Vasomotor and allergic rhinitis
Registration Number
IRCT2014051617413N3
Lead Sponsor
Baqiyatallah University of Medical Sciences, Deputy of Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
140
Inclusion Criteria

Mild allergic rhinitis patients referred to Baqiyatallah University of Medical Sciences Allergy Clinic without any age and gender limitations. Exclusion criteria: Patients consuming antihistamines and corticosteroids; refractory to antihistamines and leukotriene receptor antagonists; patients with asthma; acute and chronic rhino-sinusitis; polyposis; consuming tricyclic antidepressants; allergy to ketotifen

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rhinorrhea severity. Timepoint: Before treatment, two weeks and four weeks after treatment. Method of measurement: visual analogue score (0-10).;Itchy nose severity. Timepoint: Before treatment, two weeks and four weeks after treatment. Method of measurement: visual analogue score (0-10).;Quality of life. Timepoint: Before treatment, two weeks and four weeks after treatment. Method of measurement: Rhino-conjunctivitis quality of life questionnaire (RQLQ).;Eosinophil percent for nasal smears. Timepoint: Before treatment, two weeks and four weeks after treatment. Method of measurement: Nasal smears laboratory test.;Nasal obstruction severity. Timepoint: Before treatment, two weeks and four weeks after treatment. Method of measurement: visual analogue score (0-10).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath